Back    Zoom +    Zoom -
<Research>M Stanley Ratings, TPs on CN Biopharma Stocks (Table)
Recommend
2
Positive
7
Negative
3
Stock | Rating | TP (HK$)

EVEREST MED(01952.HK) | Equalweight | 55 -> 44
INNOVENT BIO(01801.HK) | Overweight | 130
VISEN PHARMA-B(02561.HK) | Overweight | 80 -> 50
ZAI LAB(09688.HK) | Overweight | 37.5 -> 19.5

Related NewsM Stanley Reinitiates Coverage on INNOVENT BIO w/ Rating Overweight; Catalysts for CN Biotech Sector Concentrated in 2H26

AAStocks Financial News
Website: www.aastocks.com